Form 4: Roivant Sciences Director Ilan Oren Reports Changes in Beneficial Ownership

Director Ilan Oren reports acquisition and disposal of Roivant Sciences Ltd. common shares related to director compensation and tax obligations.

Summary

• On April 17, 2025, Ilan Oren, a director of Roivant Sciences Ltd., reported changes in beneficial ownership of the company's common shares.
• Oren acquired 2,635 common shares as part of the Issuer's Non-Employee Director Compensation Plan, which were fully vested on the grant date.
• Additionally, 64 common shares were disposed of to cover tax withholding obligations related to the vesting and settlement of previously granted shares.
• Following these transactions, Oren directly owns 102,500 common shares.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, indicating standard compensation practices and compliance. Sentiment is neutral to slightly positive due to the director's continued investment in the company.

Positives

• The acquisition of shares reflects ongoing participation in the company's compensation plan.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider ownership.

Key Dates

Keywords

Roivant Sciences, Director, Beneficial Ownership, Common Shares, SEC Form 4, Compensation Plan, Tax Withholding